Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $21.7 Million - $25.9 Million
-448,500 Reduced 89.97%
50,000 $2.57 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $11.6 Million - $12.9 Million
-200,000 Reduced 28.63%
498,500 $28.9 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $12.7 Million - $14.1 Million
200,000 Added 40.12%
698,500 $44.7 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $2.96 Million - $3.35 Million
-45,000 Reduced 8.28%
498,500 $34.6 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $33.8 Million - $40 Million
493,500 Added 987.0%
543,500 $39.1 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $980,370 - $1.08 Million
13,500 Added 36.99%
50,000 $3.85 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $2.24 Million - $2.69 Million
36,500 New
36,500 $2.67 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $16.1 Million - $18.8 Million
-300,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $10.2 Million - $11.9 Million
172,000 Added 134.38%
300,000 $17.8 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $53.8 Million - $58.6 Million
-869,200 Reduced 87.16%
128,000 $8.55 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $35.8 Million - $42.7 Million
792,800 Added 387.87%
997,200 $47.6 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $12.3 Million - $13.4 Million
204,400
204,400 $12.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.